DSM reports in-line quarterly results, suspends outlook
07/05/2020 06:37
AMSTERDAM, May 7 (Reuters) - Dutch speciality chemicals
maker DSM NV DSMN.AS on Thursday reported first-quarter core
earnings in line with estimates, but suspended its annual
outlook amid market uncertainty caused by the coronavirus
crisis.
Adjusted earnings before interest, taxes, depreciation and
amortization (EBITDA) came in at 423 million euros ($457
million), in-line with a company compiled poll, and down
fractionally from 424 million euros posted last year.
Sales were flat at 2.29 billion euros.
The Dutch company expects an about 5% increase in adjusted
EBITDA for its nutrition division, but said it is too early to
provide an overall outlook as it has limited visibility on
earnings from its materials division.
($1 = 0.9264 euros)
(Reporting by Toby Sterling, Editing by Sherry Jacob-Phillips)
((toby.sterling@thomsonreuters.com; +31 20 504 5002;))